Category 2: Lived-Experience & Phenomenon Explainers · Episode 13

Why GLP-1s Are NOT the 'Easy Way Out'

Clinical Answer Capsule: Characterizing GLP-1 receptor agonists as an 'easy way out' contradicts modern endocrine pathology. Incretin therapies correct physiological hormone deficiencies in gastric motility and central satiety signaling rather than bypassing lifestyle effort. Patients on GLP-1s must still maintain high protein floors, resistance training, and hydration to sustain metabolic improvements.
Endocrine Pathology of ObesityIncretin Hormone DeficitWillpower Myth DeconstructionLean Muscle Sarcopenia PreventionCorrective Medical Therapy
Executive Action Script
"GLP-1s are not a shortcut; they are corrective endocrine tools that restore broken biological satiety signaling so healthy habits actually produce results."

Full Video Dialogue & Clinical Context

Calling a GLP-1 'the easy way out' is like calling glasses 'cheating at vision.' Taking a hormone that fixes severe metabolic dysfunction isn't dodging work - it fixes the broken engine so your hard work actually matters. You still lift heavy, prioritize protein, stay hydrated, and unlearn diet culture bullshit. GLP-1s don't do the work for you; they make the work work. Get the full scientific dismantling of diet culture shame in my book FAT BITCH at fatbitchbook.com and grab free guides at bitchesandbesties.com/armory.

🔬 Verified Clinical Reference:
Wilding JPH, et al. STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021; 384:989-1002. PMID: 33715155
Access Study: https://pubmed.ncbi.nlm.nih.gov/33715155/
Featured Armory Instrument
FAT BITCH: Killing the Willpower Myth (Book & Manifesto)
Cat Clark's radical manifesto deconstructing diet-culture shame, the willpower lie, and reclaiming metabolic autonomy.
Unlock Free Instrument in The Armory →